Research Labs | National Cancer Centre Singapore

Cellular & Molecular Research

The Division of Cellular & Molecular Research is focused on understanding the mechanistic basis of tumour development and treatment response; as well as the translation of bench-based findings to devise strategies to improve the early detection and treatment of cancers.

Medical Sciences

The Division of Medical Sciences has evolved in the last decade to one that is completely focused on the mission of translating biological discoveries into the clinic.

Clinical Trials & Epidemiological Sciences

The Division was conceived to provide support and to encourage clinical trials within NCCS.

Research News

Research NTU study could offer clues to overcoming cancer drug resistance SINGAPORE – Research by scientists from the Nanyang Technological University (NTU) has uncovered how tumours can hijack DNA repair mechanisms to resist anti-cancer drugs, as well as how this drug resistance can be reversed.

28 Sep 2026 | The Straits Times Read story

Research SingHealth Duke-NUS AMC Launches SPADE to Accelerate Precision Diagnostics and Treatment The SingHealth Duke-NUS Academic Medical Centre (AMC) today launched SPADE (Spatial Profiling and Disease Exploration), a new cross-institutional research platform that brings together clinical, biomedical and computational expertise across the AMC to better understand how diseases develop, why patients respond differently to treatments and how those research insights can be translated into more precise diagnostics and therapies in the future.

25 Sep 2026 Read story

Patient Care 新加坡研发新工具更准确预测肝癌术后复发风险肝癌患者即使成功切除肿瘤，术后仍有不少人会复发。新加坡科研团队研发一款新工具，可更准确预测患者术后复发风险，预测表现高达86%，有助医生制定更精准的治疗和追踪方案。

04 Aug 2026 | Lianhe Zaobao Read story

View All News